Excessive ROS trigger activation of the oncogene, c-Jun activation domain-binding protein 1 (Jab1), in AML patient relapse, and the upregulated Jab1 can regulate Trx by binding to Trx1, which contributes to the poor survival [11]. Here, TXN is linked to acute myeloid leukemia.